Chiefari Eusebio, Foti Daniela P, Sgarra Riccardo, Pegoraro Silvia, Arcidiacono Biagio, Brunetti Francesco S, Greco Manfredi, Manfioletti Guidalberto, Brunetti Antonio
Department of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Department of Life Sciences, University of Trieste, Trieste, Italy.
Front Endocrinol (Lausanne). 2018 Jul 3;9:357. doi: 10.3389/fendo.2018.00357. eCollection 2018.
HMGA1 (high mobility group A1) is a nonhistone architectural chromosomal protein that functions mainly as a dynamic regulator of chromatin structure and gene transcription. As such, HMGA1 is involved in a variety of fundamental cellular processes, including gene expression, epigenetic regulation, cell differentiation and proliferation, as well as DNA repair. In the last years, many reports have demonstrated a role of HMGA1 in the transcriptional regulation of several genes implicated in glucose homeostasis. Initially, it was proved that HMGA1 is essential for normal expression of the insulin receptor (INSR), a critical link in insulin action and glucose homeostasis. Later, it was demonstrated that HMGA1 is also a downstream nuclear target of the INSR signaling pathway, representing a novel mediator of insulin action and function at this level. Moreover, other observations have indicated the role of HMGA1 as a positive modulator of the Forkhead box protein O1 (FoxO1), a master regulatory factor for gluconeogenesis and glycogenolysis, as well as a positive regulator of the expression of insulin and of a series of circulating proteins that are involved in glucose counterregulation, such as the insulin growth factor binding protein 1 (IGFBP1), and the retinol binding protein 4 (RBP4). Thus, several lines of evidence underscore the importance of HMGA1 in the regulation of glucose production and disposal. Consistently, lack of HMGA1 causes insulin resistance and diabetes in humans and mice, while variations in the gene are associated with the risk of type 2 diabetes and metabolic syndrome, two highly prevalent diseases that share insulin resistance as a common pathogenetic mechanism. This review intends to give an overview about our current knowledge on the role of HMGA1 in glucose metabolism. Although research in this field is ongoing, many aspects still remain elusive. Future directions to improve our insights into the pathophysiology of glucose homeostasis may include epigenetic studies and the use of "omics" strategies. We believe that a more comprehensive understanding of HMGA1 and its networks may reveal interesting molecular links between glucose metabolism and other biological processes, such as cell proliferation and differentiation.
高迁移率族蛋白A1(HMGA1)是一种非组蛋白染色体结构蛋白,主要作为染色质结构和基因转录的动态调节因子发挥作用。因此,HMGA1参与多种基本细胞过程,包括基因表达、表观遗传调控、细胞分化与增殖以及DNA修复。近年来,许多报告表明HMGA1在涉及葡萄糖稳态的多个基因的转录调控中发挥作用。最初,已证实HMGA1对于胰岛素受体(INSR)的正常表达至关重要,胰岛素受体是胰岛素作用和葡萄糖稳态的关键环节。后来,证明HMGA1也是INSR信号通路的下游核靶点,在此水平上代表胰岛素作用和功能的新型介质。此外,其他观察结果表明HMGA1作为叉头框蛋白O1(FoxO1)的正向调节因子发挥作用,FoxO1是糖异生和糖原分解的主要调节因子,也是胰岛素以及一系列参与葡萄糖对抗调节的循环蛋白(如胰岛素生长因子结合蛋白1(IGFBP1)和视黄醇结合蛋白4(RBP4))表达的正向调节因子。因此,多条证据强调了HMGA1在葡萄糖生成和代谢调节中的重要性。一致的是,缺乏HMGA1会导致人类和小鼠出现胰岛素抵抗和糖尿病,而该基因的变异与2型糖尿病和代谢综合征的风险相关,这两种高度流行的疾病都以胰岛素抵抗作为共同的发病机制。本综述旨在概述我们目前关于HMGA1在葡萄糖代谢中作用的知识。尽管该领域的研究仍在进行中,但许多方面仍不清楚。改善我们对葡萄糖稳态病理生理学理解的未来方向可能包括表观遗传学研究和“组学”策略的应用。我们相信,对HMGA1及其网络的更全面理解可能会揭示葡萄糖代谢与其他生物过程(如细胞增殖和分化)之间有趣的分子联系。